| Series Title | European Voice |
|---|---|
| Series Details | 30/07/98, Volume 4, Number 30 |
| Publication Date | 30/07/1998 |
| Content Type | News |
|
Date: 30/07/1998 ...designed to offer companies a range of incentives to produce treatments for very rare diseases have been unveiled by Industry Commissioner Martin Bangemann. They include granting drug companies exclusive marketing rights for such products for ten years, waiving registration fees and streamlining approval procedures. |
|
| Subject Categories | Health |
